首页|新型冠状病毒感染抗病毒药物引起肝损伤的发生机制

新型冠状病毒感染抗病毒药物引起肝损伤的发生机制

扫码查看
药物性肝损伤是药物使用过程中因药物本身和/或其代谢产物,或由于特殊体质对药物的超敏感性或耐受性降低所导致.在近三年抗击新型冠状病毒感染(COVID-19)的诊治过程中,抗病毒药物起到了非常重要的作用,但国内外关于抗COVID-19药物引起肝损伤的报道较多,且其导致肝损伤的发生机制尚未明确.本文对COVID-19抗病毒药物的种类及其引起肝损伤机制的相关研究进展作一综述,旨在促进抗病毒药物的合理使用.
Pathogenesis of liver injury caused by antiviral drugs for coronavirus disease 2019
Drug-induced liver injury is caused by the drug itself and/or its metabolites during drug use or occurs due to hypersensitivity or reduced tolerance to the drug in a particular body type.In the last three years of the diagnosis and treatment of coronavirus disease 2019(COVID-19),antiviral drugs have played a very important role,but there are many reports on liver injury caused by anti-COVID-19 drugs in China and globally,with unknown pathogenesis of liver injury caused by such drugs.This article reviews the research advances in the types of antiviral drugs for COVID-19 and their mechanism in inducing liver injury,in order to promote the rational use of antiviral drugs.

Chemical and Drug Induced Liver InjurySARS-CoV-2Pathologic Processes

曾雪、李福青、李清清、王红

展开 >

遵义医科大学附属医院消化内科, 贵州 遵义 563000

化学性与药物性肝损伤 新型冠状病毒 病理过程

2024

临床肝胆病杂志
吉林大学

临床肝胆病杂志

CSTPCD北大核心
影响因子:1.428
ISSN:1001-5256
年,卷(期):2024.40(2)
  • 12